The SELECT cardiovascular outcomes trial (NEJM, 2023) showed a 20% reduction in major adverse cardiovascular events among patients with existing heart disease -- data that no other GLP-1 in this class has yet matched
The result often means less flexibility in dosing, unmanaged side effects, and little to no support beyond the prescription itself, making it harder for patients to maintain long-term results
it is about shedding the doubt that has weighed you down for far too long
Most users find that nausea peaks during dose escalation periods and subsides significantly within four to six weeks as their digestive system adapts to the medication's effects
The article names weight loss velocity, gastrointestinal tolerability, and sustained glycemic or metabolic control
The redox mechanism in cancer cells by upregulating the antiapoptotic and antioxidant moieties enhances the survival and develops resistance to the anticancer agents